Last updated on September 2015

Proteinuria in kidney disease and diabetes


Brief description of study

Proteinuria in kidney disease and diabetes

Detailed Study Description

The purpose of the study is to evaluate whether or not atrasentan is effective in delaying the worsening of kidney disease by comparing the time to serum creatinine doubling or the onset of end stage renal disease in patients with Type 2 diabetes and kidney disease.

Clinical Study Identifier: TX141457

Contact Investigators or Research Sites near you

Start Over

Stephanie Hanzl

Northeast Clinical Research Center, LLC.
Bethlehem, PA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.